Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonggi Choi

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Clinical and Molecular Hepatology|November 29, 2017
Lamivudine: fading into the mists of timeJonggi Choi, Young-Suk Lim
Hepatology (Baltimore, Md.)|June 30, 2020
REPLYJonggi Choi, Young-Suk Lim
The Kaohsiung Journal of Medical Sciences|January 27, 2021
Secondary prevention of hepatitis B virus-related hepatocellular carcinoma with current antiviral therapiesJonggi Choi, Young-Suk Lim
Ebiomedicine|December 17, 2016
Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?Jonggi Choi, Young-Suk Lim
Clinical Liver Disease|May 2, 2019
Statins and metformin for chemoprevention of hepatocellular carcinomaJonggi Choi, Lewis R Roberts
Hepatology (Baltimore, Md.)|October 6, 2020
ReplyJonggi Choi, Young-Suk Lim
Alimentary Pharmacology & Therapeutics|January 22, 2024
Editorial: Paradox of liver fat content in the spectrum of non-alcoholic fatty liver diseaseSung Won Chung, Jonggi Choi
Journal of Hepatology|July 29, 2019
Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no directionJonggi Choi, Young-Suk Lim
JAMA Internal Medicine|June 30, 2025
Study Limitations in Statin Use and Risk of Hepatocellular Carcinoma-ReplyJonggi Choi, Raymond T Chung
Alimentary Pharmacology & Therapeutics|July 6, 2026
Letter: HBsAg Loss After COVID-19 Vaccination: Implications for HBV Screening, Immunity Monitoring, and Health Worker Protection in LMICs. Authors' ReplyJonggi Choi, Raymond T Chung
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Clinical and Molecular Hepatology|November 29, 2017
Lamivudine: fading into the mists of timeJonggi Choi, Young-Suk Lim
Hepatology (Baltimore, Md.)|June 30, 2020
REPLYJonggi Choi, Young-Suk Lim
The Kaohsiung Journal of Medical Sciences|January 27, 2021
Secondary prevention of hepatitis B virus-related hepatocellular carcinoma with current antiviral therapiesJonggi Choi, Young-Suk Lim
Ebiomedicine|December 17, 2016
Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?Jonggi Choi, Young-Suk Lim
Clinical Liver Disease|May 2, 2019
Statins and metformin for chemoprevention of hepatocellular carcinomaJonggi Choi, Lewis R Roberts
Hepatology (Baltimore, Md.)|October 6, 2020
ReplyJonggi Choi, Young-Suk Lim
Alimentary Pharmacology & Therapeutics|January 22, 2024
Editorial: Paradox of liver fat content in the spectrum of non-alcoholic fatty liver diseaseSung Won Chung, Jonggi Choi
Journal of Hepatology|July 29, 2019
Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no directionJonggi Choi, Young-Suk Lim
JAMA Internal Medicine|June 30, 2025
Study Limitations in Statin Use and Risk of Hepatocellular Carcinoma-ReplyJonggi Choi, Raymond T Chung
Alimentary Pharmacology & Therapeutics|July 6, 2026
Letter: HBsAg Loss After COVID-19 Vaccination: Implications for HBV Screening, Immunity Monitoring, and Health Worker Protection in LMICs. Authors' ReplyJonggi Choi, Raymond T Chung
Pageof 14